Award of Options under LTIP

RNS Number : 0295R

Abingdon Health PLC

24 October 2023

Abingdon Health plc

("Abingdon" or "the Company")

Award of Options under LTIP

York, U.K. 24 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests, announces that, under the terms of the existing Long Term Incentive Plan established in December 2022 ("LTIP" or the "Plan"), the Company has awarded share options ("Options") over a total of 2,386,238 ordinary shares of 0.025 pence each ("Ordinary Shares") to certain directors and senior management, in order to incentivise and encourage retention in a manner that aligns with the interests of the Company's shareholders.

The Options are nil cost and will vest over a three-year vesting period. Vesting of the Options is conditional upon the business achieving certain challenging revenue, adj. EBITDA and total shareholder return criteria. The Options will become exercisable between 24 October 2026 and 24 October 2033.

The following directors and members of the senior management team (each a person discharging managerial responsibilities ("PDMR")) have been awarded options:

PDMR	Role	No. of new Options awarded under the LTIP	No. of existing Options under the LTIP	Total number of Options under the LTIP
Chris Yates	Chief Executive Officer	850,459	1,285,714	2,136,173
Chris Hand	Non-Executive Chairman	283,486	428,571	712,057
Mark Jones	Chief Operating Officer	401,376	600,000	1,001,376
Nina Garrett	Chief Technical Officer	337,156	515,000	852,156
Candice Vendetuolli	Head of QARA	183,486	285,714	469,200
Natalie Thrush	Head of HR	68,807	90,000	158,807
Liam Currivan	Head of Sales & Marketing	261,468	-	261,468

As a result of these changes, the Company now has outstanding options over 5,719,162 Ordinary Shares equal to approximately 4.7 per cent. of the Company's issued share capital.

Enquiries:

Abingdon Health plc		www.abingdonhealth.com/investors/
Chris Yates, Chief Executive Officer		Via Walbrook PR
Chris Hand, Non-Executive Chairman


Singer Capital Markets (Sole Broker and Nominated Adviser)		Tel: +44 (0)20 7496 3000
Peter Steel, Alex Bond, Jalini Kalaravy


Walbrook PR Limited	Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Phillip Marriage Alice Woodings	Mob: +44 (0)7980 541 893 / +44 (0)7867 984 082 +44 (0)7407 804 654

About Abingdon Health plc

Abingdon Health is a leading lateral flow contract research (CRO) and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes.

Abingdon Health's Abingdon Simply Test™ range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test™ ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Chris Yates
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil-cost	850,459

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Chris Hand
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil cost	283,486

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mark Jones
2	Reason for the notification
a)	Position/status	Chief Operating Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil cost	401,376

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Nina Garrett
2	Reason for the notification
a)	Position/status	Chief Technical Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil cost	337,156

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Candice Vendetuolli
2	Reason for the notification
a)	Position/status	Head of QARA
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil cost	183,486

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Natalie Thrush
2	Reason for the notification
a)	Position/status	Head of HR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil cost	68,807

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Liam Currivan
2	Reason for the notification
a)	Position/status	Head of Sales & Marketing
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each

	Identification code	GB00BLF79J41

b)	Nature of the transaction	Award of LTIP Options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			Nil cost	261,468

d)	Aggregated information	N/A single transaction

	- Aggregated volume

	- Price

e)	Date of the transaction	23^rd October 2023
f)	Place of the transaction	Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHMZMZGGFVGFZZ

TIDM	ABDX
Share Price	10.68p-2.33%
Market Cap	£27.00m

Date	24 Oct 2023
Time	07:01:02
Category	Director/PDMR dealings
ID	0295R

TIDM	ABDX
Share Price	10.68p-2.33%
Market Cap	£27.00m

Date	24 Oct 2023
Time	07:01:02
Category	Director/PDMR dealings
ID	0295R

t

Company Information

AI Summary

RNS Metadata

Company Information

AI Summary

RNS Metadata

Award of Options under LTIP